Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALPN-303 in Adult Healthy Volunteers

Next Previous
X
Search
Trial Profile

A Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALPN-303 in Adult Healthy Volunteers

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 26 Nov 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Povetacicept (Primary) ; Povetacicept (Primary)
  • Indications Sjogren's syndrome; Systemic lupus erythematosus
  • Focus Adverse reactions; First in man
  • Acronyms RUBY-1
  • Sponsors Alpine Immune Sciences

    • Most Recent Events

    • 15 Nov 2023 According to an Alpine Immune Sciences media release, data from this study were presented at the American College of Rheumatology Convergence 2023, November 10-15, 2023.
    • 03 Nov 2023 According to an Alpine Immune Sciences media release, the company presented safety, tolerability, pharmacokinetic, and pharmacodynamic data at the American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting (AANEM), November 1-3, 2023 in Phoenix, Arizona.
    • 05 Sep 2023 According to Alpine Immune Sciences media release, safety, tolerability, pharmacokinetic, and pharmacodynamic data of this study will be presented at 148th Annual American Neurological Association (ANA) Meeting in Philadelphia, PA.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top